Greenyn Biotechnology Co., Ltd (TPEX:6846)
Taiwan · Delayed Price · Currency is TWD 61.90
+0.50 (0.81%)
Aug 4, 2026, 12:42 PM CST
Greenyn Biotechnology Market Cap
Greenyn Biotechnology has a market cap or net worth of 1.66 billion as of August 4, 2026. Its market cap has decreased by -16.80% in one year.
Market Cap
1.66B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
61.90
ChartMarket Cap Chart
Since April 19, 2022, Greenyn Biotechnology's market cap has decreased from 2.03B to 1.66B, a decrease of -18.21%. That is a compound annual growth rate of -4.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 1.67B | -15.78% |
| Dec 31, 2025 | 1.98B | -8.66% |
| Dec 31, 2024 | 2.17B | 2.47% |
| Dec 29, 2023 | 2.12B | 6.41% |
| Dec 30, 2022 | 1.99B | -1.69% |
| Apr 19, 2022 | 2.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HeXun Biosciences | 2.01B |
| Gwo Xi Stem Cell Applied Technology Co. , | 1.89B |
| G&E Herbal Biotechnology | 1.86B |
| Sunny Pharmtech | 1.85B |
| Synbio Tech | 1.59B |
| Anti-Microbial Savior BioteQ | 1.59B |
| TaiRx | 1.51B |
| Andros Pharmaceuticals Co.,Ltd | 1.43B |